Epigenetic Alterations in Pancreatic Cancer Metastasis

Pancreatic cancer is the third leading cause of cancer-related deaths in the United States. Pancreatic ductal adenocarcinoma (PDA) is the most common (90%) and aggressive type of pancreatic cancer. Genomic analyses of PDA specimens have identified the recurrent genetic mutations that drive PDA initi...

Full description

Bibliographic Details
Main Authors: Sarah S. Wang, Jihao Xu, Keely Y. Ji, Chang-Il Hwang
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/11/8/1082
_version_ 1797524556162793472
author Sarah S. Wang
Jihao Xu
Keely Y. Ji
Chang-Il Hwang
author_facet Sarah S. Wang
Jihao Xu
Keely Y. Ji
Chang-Il Hwang
author_sort Sarah S. Wang
collection DOAJ
description Pancreatic cancer is the third leading cause of cancer-related deaths in the United States. Pancreatic ductal adenocarcinoma (PDA) is the most common (90%) and aggressive type of pancreatic cancer. Genomic analyses of PDA specimens have identified the recurrent genetic mutations that drive PDA initiation and progression. However, the underlying mechanisms that further drive PDA metastasis remain elusive. Despite many attempts, no recurrent genetic mutation driving PDA metastasis has been found, suggesting that PDA metastasis is driven by epigenetic fluctuations rather than genetic factors. Therefore, establishing epigenetic mechanisms of PDA metastasis would facilitate the development of successful therapeutic interventions. In this review, we provide a comprehensive overview on the role of epigenetic mechanisms in PDA as a critical contributor on PDA progression and metastasis. In particular, we explore the recent advancements elucidating the role of nucleosome remodeling, histone modification, and DNA methylation in the process of cancer metastasis.
first_indexed 2024-03-10T08:59:06Z
format Article
id doaj.art-133868449b2545ad9be1220f1e0d5d5c
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-03-10T08:59:06Z
publishDate 2021-07-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-133868449b2545ad9be1220f1e0d5d5c2023-11-22T06:54:31ZengMDPI AGBiomolecules2218-273X2021-07-01118108210.3390/biom11081082Epigenetic Alterations in Pancreatic Cancer MetastasisSarah S. Wang0Jihao Xu1Keely Y. Ji2Chang-Il Hwang3Department of Microbiology and Molecular Genetics, College of Biological Sciences, University of California Davis, Davis, CA 95616, USADepartment of Microbiology and Molecular Genetics, College of Biological Sciences, University of California Davis, Davis, CA 95616, USADepartment of Microbiology and Molecular Genetics, College of Biological Sciences, University of California Davis, Davis, CA 95616, USADepartment of Microbiology and Molecular Genetics, College of Biological Sciences, University of California Davis, Davis, CA 95616, USAPancreatic cancer is the third leading cause of cancer-related deaths in the United States. Pancreatic ductal adenocarcinoma (PDA) is the most common (90%) and aggressive type of pancreatic cancer. Genomic analyses of PDA specimens have identified the recurrent genetic mutations that drive PDA initiation and progression. However, the underlying mechanisms that further drive PDA metastasis remain elusive. Despite many attempts, no recurrent genetic mutation driving PDA metastasis has been found, suggesting that PDA metastasis is driven by epigenetic fluctuations rather than genetic factors. Therefore, establishing epigenetic mechanisms of PDA metastasis would facilitate the development of successful therapeutic interventions. In this review, we provide a comprehensive overview on the role of epigenetic mechanisms in PDA as a critical contributor on PDA progression and metastasis. In particular, we explore the recent advancements elucidating the role of nucleosome remodeling, histone modification, and DNA methylation in the process of cancer metastasis.https://www.mdpi.com/2218-273X/11/8/1082pancreatic cancerepigeneticsmetastasisDNA methylation
spellingShingle Sarah S. Wang
Jihao Xu
Keely Y. Ji
Chang-Il Hwang
Epigenetic Alterations in Pancreatic Cancer Metastasis
Biomolecules
pancreatic cancer
epigenetics
metastasis
DNA methylation
title Epigenetic Alterations in Pancreatic Cancer Metastasis
title_full Epigenetic Alterations in Pancreatic Cancer Metastasis
title_fullStr Epigenetic Alterations in Pancreatic Cancer Metastasis
title_full_unstemmed Epigenetic Alterations in Pancreatic Cancer Metastasis
title_short Epigenetic Alterations in Pancreatic Cancer Metastasis
title_sort epigenetic alterations in pancreatic cancer metastasis
topic pancreatic cancer
epigenetics
metastasis
DNA methylation
url https://www.mdpi.com/2218-273X/11/8/1082
work_keys_str_mv AT sarahswang epigeneticalterationsinpancreaticcancermetastasis
AT jihaoxu epigeneticalterationsinpancreaticcancermetastasis
AT keelyyji epigeneticalterationsinpancreaticcancermetastasis
AT changilhwang epigeneticalterationsinpancreaticcancermetastasis